Eculizumab (anti-Complement C5) - Primary antibody, specific to C5, >95%, Human IgG2+Human IgG4, INHIBITOR of Complement C5 inhibitor, INHIBITOR of Complement C5 inhibitor

CAS: 219685-50-4 Cat. No.: Ab170870
AVAILABLE TO ORDER
GRADE & PURITY Animal Free ? Animal-free — produced without animal-derived components to reduce contamination risk. Use in biomanufacturing and culture avoiding animal-origin material. Carrier Free ? Carrier-free — supplied without added carrier protein/stabilizer. Use when carriers (e.g. BSA) would interfere with conjugation or sensitive assays. Recombinant ? Recombinant — produced via recombinant expression for defined sequence and consistency. Use for reproducible, animal-free proteins of known origin. Validated ? Validated grade — performance confirmed in defined applications before release. Use when you want documented assurance the reagent works as stated. ExactAb™ ? ExactAb™ — Aladdin's antibody line emphasizing precision and validated quality. Use for reliable, specificity-validated antibody applications. Low Endotoxin ? Low-endotoxin grade — endotoxin reduced to low controlled levels. Use in sensitive biological work where high endotoxin would interfere. Azide Free ? Azide-free — without sodium azide preservative. Use in conjugations, cell work, or assays where azide is toxic or inhibitory. ≥95%(SDS-PAGE&SEC-HPLC) See COA
Application
Animal Model, ELISA, Flow Cytometry, Functional Assay
Host species
Human
Reactive species
Human, Mouse
Isotype
Human IgG2+Human IgG4
Conjugation
Unconjugated
 ·  off list, applied to all prices below.
Size
Status
Price
Qty
100μg
Ab170870-100μg
1-2 wks(?)
Item is derived from our semi-finished stock and is processed in 1-2 weeks.
$187.90
1mg
Ab170870-1mg
2
$748.90
5mg
Ab170870-5mg
1
$2,815.90
10mg
Ab170870-10mg
1-2 wks(?)
Item is derived from our semi-finished stock and is processed in 1-2 weeks.
$3,723.90
Enter a quantity for the sizes you want to add.
🧪

Why this grade

Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA Animal Free,Azide Free,Carrier Free,ExactAb™,Low Endotoxin,Recombinant,Validated for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -80°C,Avoid repeated freezing and thawing Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Overview

Eculizumab (anti-Complement C5) is a long-acting humanized monoclonal antibody targeted against complement C5. Eculizumab (anti-Complement C5) inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement system including the formation of membrane attack complex (MAC). Eculizumab (anti-Complement C5) has the potential for haemolysis research.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Specifications

Product Name
Eculizumab (anti-Complement C5) - Primary antibody, specific to C5, >95%, Human IgG2+Human IgG4, INHIBITOR of Complement C5 inhibitor
Synonyms
Anaphylatoxin C5a analog antibody | C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4 antibody | C5 antibody | C5a anaphylatoxin antibody | C5a antibody | C5b antibody | CO5_HUMAN antibody | Complement C5 alpha'' chain antibody | Complemen
Specifications & Purity
Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species
Human
Specificity
C5
Conjugation
Unconjugated
Grade
Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action Type
INHIBITOR
Mechanism of action
INHIBITOR of Complement C5 inhibitor
Isotype
Human IgG2+Human IgG4
Light Chain Type
kappa
SDS-PAGE
26.1 kDa (Light Chain) & 51.6 kDa (Heavy Chain), under reducing conditions; 165.6 kDa, under non-reducing conditions.
Purification Method
Protein A purified
Purity
>95%
Concentration
See COA
CAS
219685-50-4
Storage and Shipping
Shape
Liquid
Storage
Store at -80°C,Avoid repeated freezing and thawing
Shipped In
Dry ice packs + Cold packs
Stability And Storage
Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
Images

Eculizumab (anti-Complement C5) (Ab170870) - SEC
The purity of Eculizumab (anti-Complement C5) (Ab170870) is more than 95% verified by HPLC.

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
SubclassAmino acids, peptides, and analogues
Intermediate Tree Nodes Peptides
Direct ParentDipeptides
Alternative Parents Leucine and derivatives  N-carbamoyl-alpha amino acids and derivatives  N-acyl-alpha amino acids  Tryptamines and derivatives  Alpha amino acid amides  Indolecarboxylic acids  3-alkylindoles  Piperidinecarboxamides  Pyrrole carboxylic acids and derivatives  Medium-chain fatty acids  Amino fatty acids  Aralkylamines  Branched fatty acids  Heterocyclic fatty acids  Benzenoids  Substituted pyrroles  N-substituted carboxylic acid imides  N-acyl amines  Heteroaromatic compounds  Dicarboximides  Ureas  Amino acids  Carboxylic acids  Azacyclic compounds  Monocarboxylic acids and derivatives  Organic oxides  Organopnictogen compounds  Hydrocarbon derivatives  Carbonyl compounds  Monoalkylamines  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Alpha-dipeptide - Leucine or derivatives - N-acyl-alpha-amino acid - N-acyl-alpha amino acid or derivatives - N-carbamoyl-alpha-amino acid or derivatives - Alpha-amino acid amide - Indolecarboxylic acid - Indolecarboxylic acid derivative - Triptan - Alpha-amino acid or derivatives - 3-alkylindole - Indole - Indole or derivatives - 1-piperidinecarboxamide - Piperidinecarboxamide - Medium-chain fatty acid - Pyrrole-1-carboxylic acid or derivatives - Heterocyclic fatty acid - Branched fatty acid - Aralkylamine - Amino fatty acid - N-acyl-amine - Carboxylic acid imide, n-substituted - Fatty acyl - Fatty acid - Benzenoid - Piperidine - Substituted pyrrole - Dicarboximide - Carboxylic acid imide - Heteroaromatic compound - Pyrrole - Urea - Amino acid or derivatives - Carbonic acid derivative - Amino acid - Organoheterocyclic compound - Carboxylic acid - Azacycle - Monocarboxylic acid or derivatives - Organic oxygen compound - Organic nitrogen compound - Organic oxide - Organopnictogen compound - Organonitrogen compound - Organooxygen compound - Carbonyl group - Amine - Primary aliphatic amine - Hydrocarbon derivative - Primary amine - Aromatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.
External Descriptors Not available
3D Structure
Interactive Chemical Structure Model





Associated Targets(Human)
C5 Tclin Complement C5 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Mechanisms of Action
Certificates(CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot NumberCertificate TypeDateItem
ZJ23F1001464Certificate of AnalysisNov 01, 2023 Ab170870
ZJ23F1001463Certificate of AnalysisNov 01, 2023 Ab170870
Documents & Articles
Solution Calculators
Reviews

Customer Reviews

Need help choosing the grade?

Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.

View Animal Free grade guide → View Carrier Free grade guide → View Recombinant grade guide → View Validated grade guide → View ExactAb™ grade guide → View Low Endotoxin grade guide → View Azide Free grade guide →

Related Products

Mouse Anti-Human IgM Antibody - Secondary antibody, for ELISA various applications, from Human, generated in Mouse, IgG1
Mouse Anti-Human IgG H&L (HRP) - Secondary antibody, for ELISA various applications, from Human, generated in Mouse, IgG1
Goat Anti-Human IgG H&L (HRP) - Secondary antibody, for WB,ELISA,IHC various applications, from Human, generated in Goat, IgG
Mouse Anti-Human IgG Antibody - Secondary antibody, for ELISA,CLIA various applications, from Human, generated in Rat, IgG1
Human IgG - Isotype Control Antibody, for WB,CLIA,LF,EIA,PRTIA various applications, generated in Human, >95%, IgG
Goat Anti-Human IgG Antibody - Secondary antibody, ≥ 95%
Mouse Anti-Human IgA H&L Antibody - Secondary antibody, Mouse IgG1
Goat Anti-Human IgG (HRP) - Secondary antibody
Goat Anti-Human IgG (Biotin) - Secondary antibody
Goat Anti-Human IgG (Cy5) - Secondary antibody
Goat Anti-Human IgG (APC) - Secondary antibody
Goat Anti-Human IgG (PE) - Secondary antibody
Goat Anti-Human IgG (TRITC) - Secondary antibody
Goat Anti-Human IgG (FITC) - Secondary antibody
Tesidolumab (anti-Complement C5) - Primary antibody, specific to C5, >95%, Human IgG1, BINDING AGENT of Complement C5 binding agent
Ravulizumab (anti-Complement C5) - Primary antibody, specific to C5, >95%, Human IgG2, INHIBITOR of Complement C5 inhibitor
Mouse Anti-Human IgE epsilon chain Antibody - Secondary antibody
Goat Anti-Human IgG Fc Antibody - Secondary antibody, Goat IgG
Crovalimab (anti-Complement C5) - Primary antibody, specific to C5, Human IgG1, INHIBITOR of Complement C5 inhibitor
Pozelimab (anti-Complement C5) - Primary antibody, specific to C5, Human IgG4SP, INHIBITOR of Complement C5 inhibitor
Human IgG2-Kappa - Isotype Control Antibody, Human IgG2
Human IgG3-kappa - Isotype Control Antibody, Human IgG3
Vilobelimab (anti-Complement C5) - Primary antibody, specific to C5, Human IgG4SP, INHIBITOR of Complement C5 inhibitor
Human IgG1-kappa, anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD, Human IgG1
Human IgG4-kappa - Isotype Control Antibody, IgG4
Goat Anti-Human IgG (AF647) - Secondary antibody, IgG
Goat Anti-Human IgG (AF405) - Secondary antibody, IgG
Human IgG (FITC) - Isotype Control Antibody, IgG
Human IgG (APC) - Isotype Control Antibody, IgG
Human IgG (PE) - Isotype Control Antibody, IgG
Human IgG1(P331S/E430G)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(P331S/E430G)
Human IgG1(D265A/N297A)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(D265A/N297A)
Human IgG1(K409R/E356D/M358L)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(K409R/E356D/M358L)
Human IgG1(P329G/E356D/M358L)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(P329G/E356D/M358L)
Human IgG1(F405L)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(F405L)
Human IgG1(N297Q)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(N297Q)
Human IgG (Biotin) - Isotype Control Antibody, IgG
Human IgG1(N297S)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(N297S)
Human IgG1(E233A/L235A)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(E233A/L235A)
Human IgG1(K214R/N297A)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(K214R/N297A)
Human IgG1(K214R/L234A/L235A)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(K214R/L234A/L235A)
Human IgG1(N297A/E356D/M358L)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(N297A/E356D/M358L)
Human IgG1(L234F/L235E)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(L234F/L235E)
Human IgG1(D265A)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(D265A)
Human IgG1(K214R/L234F/L235E/P331S)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(K214R/L234F/L235E/P331S)
Human IgG1(K214R/E356D/M358L)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(K214R/E356D/M358L)
Human IgG1(L234A/L235A/G237A)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(L234A/L235A/G237A)
Human IgG1(L234A/L235A/F405L)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(L234A/L235A/F405L)
Human IgG1(D270N)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(D270N)
Human IgG4(S228P)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG4(S228P)
Human IgG1(N297A)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(N297A)
Human IgG4(S228P/L235E/P329G)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG4(S228P/L235E/P329G)
Human IgG1-lambda1, anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD, Human IgG1
Human IgG1-lambda2, anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD, Human IgG1
Goat Anti-Human IgG (AF555) - Secondary antibody, IgG
Lendalizumab (anti-Complement C5) - Primary antibody, specific to C5, Human IgG2SA
Human IgG1-kappa (AF405), anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD
Human IgG1-kappa (AF647), anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD
Human IgG1-kappa (APC), anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD
Human IgG1-kappa (Biotin), anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD
Human IgG1-kappa (AF700), anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD
Human IgG1-kappa (FITC), anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD
Human IgG1-kappa (AF555), anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD
Centrose patent anti-dysadherin (anti-Dysadherin) - Primary antibody, specific to FXYD5
Human IgG (AF647) - Isotype Control Antibody
Human IgG (AF488) - Isotype Control Antibody
Human IgG (AF700) - Isotype Control Antibody
Human IgG (AF405) - Isotype Control Antibody
Goat Anti-Human IgG (AF488) - Secondary antibody
Goat Anti-Human IgG Fc (Cy5) - Secondary antibody
Goat Anti-Human IgG Fc (AF555) - Secondary antibody, specific to Human IgG Fc
Goat Anti-Human IgG Fc (TRITC) - Secondary antibody
Goat Anti-Human IgG Fc (AF700) - Secondary antibody, specific to Human IgG Fc
Goat Anti-Human IgG Fc (AF405) - Secondary antibody
Goat Anti-Human IgG Fc (Biotin) - Secondary antibody, specific to Human IgG Fc
Goat Anti-Human IgG Fc (AF647) - Secondary antibody
Goat Anti-Human IgG Fc (FITC) - Secondary antibody, specific to Human IgG Fc
Human IgG (AF555) - Isotype Control Antibody

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.